China Intravenous (IV) Iron Drugs Market Research Report Forecast 2017-2021

April 2017 | 118 pages | ID: CC4F809C422EN
S&P Consulting

Abstracts

The China Intravenous (IV) Iron Drugs Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Intravenous (IV) Iron Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Intravenous (IV) Iron Drugs market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

AMAG Pharmaceuticals
Actavis
Galenica
Vifor Pharma
Luitpold Pharmaceuticals
Pharmacosmos A/S
American Regent
Fresenius Medical Care AG & Co. KGaA
Anofi US

China Intravenous (IV) Iron Drugs Market: Product Segment Analysis

Type 1
Type 2
Type 3

China Intravenous (IV) Iron Drugs Market: Application Segment Analysis

Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

China Intravenous (IV) Iron Drugs Market Research Report Forecast 2017-2021

CHAPTER 1 INTRAVENOUS (IV) IRON DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Intravenous (IV) Iron Drugs
1.2 Intravenous (IV) Iron Drugs Market Segmentation by Type
  1.2.1 China Production Market Share of Intravenous (IV) Iron Drugs by Type 1n 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Intravenous (IV) Iron Drugs Market Segmentation by Application
  1.3.1 Intravenous (IV) Iron Drugs Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Intravenous (IV) Iron Drugs (2012-2021)

CHAPTER 2 CHINA ECONOMIC IMPACT ON INTRAVENOUS (IV) IRON DRUGS INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Intravenous (IV) Iron Drugs Industry

CHAPTER 3 CHINA INTRAVENOUS (IV) IRON DRUGS MARKET COMPETITION BY MANUFACTURERS

3.1 China Intravenous (IV) Iron Drugs Production and Share by Manufacturers (2015 and 2016)
3.2 China Intravenous (IV) Iron Drugs Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Intravenous (IV) Iron Drugs Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Intravenous (IV) Iron Drugs Manufacturing Base Distribution, Production Area and Product Type
3.5 Intravenous (IV) Iron Drugs Market Competitive Situation and Trends
  3.5.1 Intravenous (IV) Iron Drugs Market Concentration Rate
  3.5.2 Intravenous (IV) Iron Drugs Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA INTRAVENOUS (IV) IRON DRUGS CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China Intravenous (IV) Iron Drugs Capacity, Production and Growth (2012-2017)
4.2 China Intravenous (IV) Iron Drugs Revenue and Growth (2012-2017)
4.3 China Intravenous (IV) Iron Drugs Production, Consumption, Export and Import (2012-2017)

CHAPTER 5 CHINA INTRAVENOUS (IV) IRON DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Intravenous (IV) Iron Drugs Production and Market Share by Type (2012-2017)
5.2 China Intravenous (IV) Iron Drugs Revenue and Market Share by Type (2012-2017)
5.3 China Intravenous (IV) Iron Drugs Price by Type (2012-2017)
5.4 China Intravenous (IV) Iron Drugs Production Growth by Type (2012-2017)

CHAPTER 6 CHINA INTRAVENOUS (IV) IRON DRUGS MARKET ANALYSIS BY APPLICATION

6.1 China Intravenous (IV) Iron Drugs Consumption and Market Share by Application (2012-2017)
6.2 China Intravenous (IV) Iron Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA INTRAVENOUS (IV) IRON DRUGS MANUFACTURERS ANALYSIS

7.1 AMAG Pharmaceuticals
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Business Overview
7.2 Actavis
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Business Overview
7.3 Galenica
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Business Overview
7.4 Vifor Pharma
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Business Overview
7.5 Luitpold Pharmaceuticals
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Business Overview
7.6 Pharmacosmos A/S
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Business Overview
7.7 American Regent
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Business Overview
7.8 Fresenius Medical Care AG & Co. KGaA
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Business Overview
7.9 Anofi US
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Business Overview

CHAPTER 8 INTRAVENOUS (IV) IRON DRUGS MANUFACTURING COST ANALYSIS

8.1 Intravenous (IV) Iron Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Intravenous (IV) Iron Drugs

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Intravenous (IV) Iron Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Intravenous (IV) Iron Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA INTRAVENOUS (IV) IRON DRUGS MARKET FORECAST (2017-2021)

12.1 China Intravenous (IV) Iron Drugs Production, Revenue Forecast (2017-2021)
12.2 China Intravenous (IV) Iron Drugs Production, Consumption Forecast by Regions (2017-2021)
12.3 China Intravenous (IV) Iron Drugs Production Forecast by Type (2017-2021)
12.4 China Intravenous (IV) Iron Drugs Consumption Forecast by Application (2017-2021)
12.5 Intravenous (IV) Iron Drugs Price Forecast (2017-2021)

CHAPTER 13 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Intravenous (IV) Iron Drugs
Figure China Production Market Share of Intravenous (IV) Iron Drugs by Type 1n 2016
Table Intravenous (IV) Iron Drugs Consumption Market Share by Application in 2016
Figure China Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Table China Intravenous (IV) Iron Drugs Capacity of Key Manufacturers (2015 and 2016)
Table China Intravenous (IV) Iron Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Intravenous (IV) Iron Drugs Capacity of Key Manufacturers in 2015
Figure China Intravenous (IV) Iron Drugs Capacity of Key Manufacturers in 2016
Table China Intravenous (IV) Iron Drugs Production of Key Manufacturers (2015 and 2016)
Table China Intravenous (IV) Iron Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Intravenous (IV) Iron Drugs Production Share by Manufacturers
Figure 2016 Intravenous (IV) Iron Drugs Production Share by Manufacturers
Table China Intravenous (IV) Iron Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Intravenous (IV) Iron Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Intravenous (IV) Iron Drugs Revenue Share by Manufacturers
Table 2016 China Intravenous (IV) Iron Drugs Revenue Share by Manufacturers
Table China Market Intravenous (IV) Iron Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Intravenous (IV) Iron Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Intravenous (IV) Iron Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Intravenous (IV) Iron Drugs Product Type
Figure Intravenous (IV) Iron Drugs Market Share of Top 3 Manufacturers
Figure Intravenous (IV) Iron Drugs Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table AMAG Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Actavis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Actavis Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Actavis Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Galenica Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Galenica Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Galenica Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Vifor Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Vifor Pharma Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Vifor Pharma Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Luitpold Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Pharmacosmos A/S Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pharmacosmos A/S Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Pharmacosmos A/S Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table American Regent Basic Information, Manufacturing Base, Production Area and Its Competitors
Table American Regent Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table American Regent Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Fresenius Medical Care AG & Co. KGaA Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Fresenius Medical Care AG & Co. KGaA Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Fresenius Medical Care AG & Co. KGaA Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Anofi US Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Anofi US Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Anofi US Intravenous (IV) Iron Drugs Market Share (2012-2017)
Figure Production Revenue Share of Intravenous (IV) Iron Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Intravenous (IV) Iron Drugs by Type
Table China Intravenous (IV) Iron Drugs Price by Type (2012-2017)
Figure China Intravenous (IV) Iron Drugs Production Growth by Type (2012-2017)
Table China Intravenous (IV) Iron Drugs Consumption by Application (2012-2017)
Table China Intravenous (IV) Iron Drugs Consumption Market Share by Application (2012-2017)
Figure China Intravenous (IV) Iron Drugs Consumption Market Share by Application in 2015
Table China Intravenous (IV) Iron Drugs Consumption Growth Rate by Application (2012-2017)
Figure China Intravenous (IV) Iron Drugs Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Intravenous (IV) Iron Drugs
Figure Manufacturing Process Analysis of Intravenous (IV) Iron Drugs
Figure Intravenous (IV) Iron Drugs Industrial Chain Analysis
Table Raw Materials Sources of Intravenous (IV) Iron Drugs Major Manufacturers in 2015
Table Major Buyers of Intravenous (IV) Iron Drugs
Table Distributors/Traders List
Figure China Intravenous (IV) Iron Drugs Capacity, Production and Growth Rate Forecast (2017-2021)
Figure China Intravenous (IV) Iron Drugs Revenue and Growth Rate Forecast (2017-2021)
Table China Intravenous (IV) Iron Drugs Production, Import, Export and Consumption Forecast (2017-2021)
Table China Intravenous (IV) Iron Drugs Production Forecast by Type (2017-2021)
Table China Intravenous (IV) Iron Drugs Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

AMAG Pharmaceuticals, Actavis, Galenica, Vifor Pharma, Luitpold Pharmaceuticals, Pharmacosmos A/S, American Regent, Fresenius Medical Care AG & Co. KGaA, Anofi US, Takeda Pharmaceutical